HNB
RVMD icon

Huntington National Bank’s Revolution Medicines RVMD Stock Holding History

Huntington National Bank’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$107K Buy
572
+288
+101% +$42.1K ﹤0.01% 1127
2026
Q1 		$27.6K Buy
284
+9
+3% +$909 ﹤0.01% 1541
2025
Q4 		$21.9K Buy
+275
New +$18K ﹤0.01% 1548
2025
Q1 		– Sell
-66
Closed -$2.89K – 4231
2024
Q4 		$2.89K Buy
+66
New +$3.33K ﹤0.01% 2166

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Huntington National Bank's RVMD Position: Q2 2026 in Review

Huntington National Bank increased its Revolution Medicines (RVMD) stake by 101% in Q2 2026, buying an estimated $42.1K and bringing the position to 572 shares worth $107K. The position accounts for ﹤0.01% of the portfolio, ranked #1127.

Huntington National Bank first reported a position in RVMD in Q4 2024 and has held it in 4 quarters since. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Huntington National Bank held 572 shares of Revolution Medicines worth $107K as of Q2 2026.
  • Huntington National Bank bought 288 Revolution Medicines shares in Q2 2026, an estimated $42.1K.
  • Revolution Medicines made up ﹤0.01% of Huntington National Bank's portfolio in Q2 2026, its #1127 holding.
  • Huntington National Bank first reported a position in Revolution Medicines in Q4 2024 and has held it in 4 quarters since.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Huntington National Bank's 13F filing for Q2 2026, filed 13 Aug 2026.